Synthetic retinoids: recent developments concerning structure and clinical utility.
Kagechika
Hiroyuki
H
School of Biomedical Science, Tokyo Medical and Dental University, 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan. kage.omc@tmd.ac.jp
Shudo
Koichi
K
D000276:Adjuvants, Immunologic / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D016588:Anticarcinogenic Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D001896:Boron Compounds / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008024:Ligands; D018696:Neuroprotective Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D018168:Receptors, Retinoic Acid / Q000187:drug effects*; D047488:Retinoid X Receptors / Q000187:drug effects; D012176:Retinoids / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D016588:Anticarcinogenic Agents; D000970:Antineoplastic Agents; D001896:Boron Compounds; D003879:Dermatologic Agents; D008024:Ligands; D018696:Neuroprotective Agents; D018168:Receptors, Retinoic Acid; D047488:Retinoid X Receptors; D012176:Retinoids